PharmExec Direct:
Having trouble viewing this e-mail? Click here.
June 7, 2012 | ISSUE NUMBER 254 VOL 8
Event Drug Innovation — Alive and Well at ASCO!
This year's annual meeting of the American Society of Clinical Oncology offered new hope even to patients with metastatic disease, writes John Otrompke. Improved results in progression-free survival in clinical trials suggest that many forms of cancer may soon take on a more chronic form ...Read more
Case Study: How a Biotech Saved $600,000 on a CRO Contract
Download a new case study to discover how a small biotech applied innovative eClinical software to:
* Save $600,000 on a single Phase II outsourcing contract
* Compress the contracting cycle-time from three months to two weeks
* Form a more constructive and collaborative working relationship with their CRO Download Now
Legal FDA User Fee Legislation Heads Towards Finish Line
Legislation to reauthorize FDA user fee programs sailed through the House and Senate last month, setting the stage for leading legislators to resolve their differences and agree on a compromise measure. House and Senate leaders are now aiming to come together in the next two weeks or so to hash out the final language ...Read More
Video Pharma Four: Pharm Exec's Latest Video Round-Up
Four minutes, four stories from the pharma industry. This week: Risk-based monitoring; pharma's anemic R&D growth; public-private partnerships in Europe; and the Congress focus on FDA User fee legislation ...Read More
Advertisement
The Basics of the Sunshine Act and the Implications for Your Business
Live Webcast: Tuesday, June 12, 2012 at 2:00PM EDT
Register Free at http://www.pharmexec.com/basics
Clinical Trials Questioning Enrollment Performance "Facts"
Kenneth A. Getz reports on new Tufts' research that counters the previously held "fact" that 20% of all investigative sites fail to enroll a single patient ...Read more
// Hans Bishop, former Chief Operating Officer of Dendreon, was appointed Executive Chair of the Board at Genesis Biopharma (Los Angeles, CA). // Constellation Pharmaceuticals (Cambridge, MA) named Dr Keith Dionne as CEO and President. // David Jaworski joined Lachman Consultants (Westbury, NY) as a Director in its Compliance Practice. // Swedish speciality pharma company Meda appointed Maria Carell as Regional Director for the US.
Advertisement Optimizing R&D Spending at Hospira
Live Webcast: Wednesday, June 20, 2012 at 01:00 PM EDT http://www.pharmexec.com/hospira
